Back

Analysis of baroreflex activation therapy in patients with heart failure with reduced ejection fraction on current era guideline-directed medical therapy

2026-02-03 cardiovascular medicine Title + abstract only
View on medRxiv
Show abstract

BackgroundGuideline-directed medical therapy (GDMT) has been shown to improve mortality and/or symptoms in heart failure with reduced ejection fraction (HFrEF). Medical devices also play an important role in improved quality of life and overall symptom relief for HFrEF patients. Baroreflex Activation Therapy (BAT) increases parasympathetic nervous system activity by stimulating the carotid baroreceptors, thereby reducing symptoms. Herein, we analyzed the effects of BAT on hospitalization, atrial...

Predicted journal destinations